THE DEAL, AT A GLANCE
From the announcementAdaptyv Biosystems
01What it doesFounded in 2021 by Julian Englert, CEO, and Daniel Nakhaee-Zadeh, CTO, Adaptyv Bio develops a cloud-connected, high-throughput automated wet lab platform engineered to…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Highland Europe, with participation, ByFounders, Y CombinatorFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedAdaptyv Biosystems raised $40M Series A, announced 2026-08-31From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersAdaptyv Biosystems is using Series A capital to expand a cloud-connected automated wet lab platform positioned as the physical execution layer for agentic biology.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Adaptyv Biosystems · Financing Record
Explore source-linked visual explanations for Adaptyv Biosystems. Unsupported claims are withheld while source review continues.
Record 11370 · Recorded date: 2026-08-31
Explore company records →